Zogenix, Inc. is an innovative pharmaceutical company committed to developing and commercializing unique therapies that address specific clinical needs for people living with rare diseases.

Our focused strategy centers on advancing late-stage product candidates and identifying clear pathways for clinical development and regulatory strategies in order to provide access to differentiated medicines.

We continually review opportunities identified by our business development team and strategic investment partners. To discuss potential business development opportunities, please contact:

This website uses cookies to ensure you get the best experience on our website. Here's our cookie policy.

I Accept